Introducing Abiraterone Acetate, the generic for Zytiga, Anti-Cancer Tablet – a potent androgen biosynthesis inhibitor designed for advanced prostate cancer treatment. It suppresses testosterone production by inhibiting CYP17 enzyme activity, thereby reducing tumor growth and improving survival outcomes. Experience targeted endocrine therapy with consistent efficacy and improved quality of life for hormone-dependent malignancies.